COLUMBIA, Md., Sept. 18 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation announced today that it will be presenting at the upcoming UBS Global Life Sciences conference in New York, NY. The conference is being held September 22-25, 2008 at the Grand Hyatt hotel. Pete Buzy, CFO will be presenting on Wednesday, September 24, 2008 at 2:30 p.m. Eastern Time.
A live audio webcast link of Martek's presentation can be accessed at: http://investors.martek.com/
Martek Biosciences Corporation is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The company produces life'sDHA(TM), a sustainable and vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, beverages, infant formula, and supplements. The company also produces life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, from a sustainable, vegetarian source, for use in infant formula. For more information on Martek Biosciences Corporation, visit http://www.martek.com/.
Contact: Kyle Stults Investor Relations (410) 740-0081
